A multitude of new treatment options for individuals living with type 1 diabetes mellitus (T1DM) are currently in development or have recently been approved. Recognizing the limitations of currently available insulin preparations, the focus of research endeavors and newly marketed products hinges on the...
A multitude of new treatment options for individuals living with type 1 diabetes mellitus (T1DM) are currently in development or have recently been approved. Recognizing the limitations of currently available insulin preparations, the focus of research endeavors and newly marketed products hinges on the...
Type 2 diabetes mellitus is characterized by a long and changing natural history. Personal circumstances and preferences also condition the actual effectiveness and safety of drugs used. In recent decades, modern drugs have markedly expanded and improved therapeutic options. However, their effectiveness ...
1. Fig. 1 Established and emerging treatments for diabetes-associated lower urinary tract dysfunction (LUTD) in diabetes mellitus (DM) Full size image Effects of established medications on LUTD in diabetes Guideline-recommended treatments of LUTD include α1-adrenoceptor antagonists, 5α-reductase ...
of β-cells from stem cells and their potential applications in disease modeling, drug discovery and clinical therapy. Finally, we have discussed the current challenges in developing stem cell-based therapeutic strategies for improving the treatment of diabetes. Although some significant technical hurdles...
Type 1 Diabetes Type 2 Diabetes Famous Diabetics Treatment for Diabetes Self Monitoring Food Planning Exercise Hypoglycemia Hyperglycemia Taking Insulin Insulin Pump Diabetes, often referred to by doctors as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glu...
Do we need new treatments for type 2 diabetes? Diagnosis of type 2 diabetes mellitus encompasses multiple pathophysiological and clinical situations. Type 2 diabetes mellitus is characterized by a long ... F Gomez-Peralta,C Abreu Padín - 《Endocrinología Y Nutrición》 被引量: 35发表: 2014年...
Diabetic peripheral neuropathy (DPN) is a complication of diabetes mellitus that occurs in both type 1 and type 2 diabetics. This complication is estimated to be prevalent in approximately 50% of the diabetic population and is associated with significant morbidity and mortality. Painful DPNs affect...
showed that intensive glycaemic control did not reduce the risk of hospitalization for HF [34]. Moreover, several retrospective studies suggest worse prognosis in patients with diabetes mellitus and HF with an HbA1c less than 7%. The relationship between glycaemic control and HF outcomes is made ...
1.A method for identifying a subject at risk for a disorder associated with diabetes, said disorder being characterized by abnormally high levels of glycated CD59 protein, comprising;obtaining a level of the amount of K41-glycated CD59 from a sample obtained from the subject, andcomparing the le...